Platform
Features
Pricing
1 follower
Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.
Industries
Headquarters
Employees
Links
Daniel O’Connell
19 members
7 members
4 members
3 members
Syneos Health
17 followers
A1 BioChem Labs
2 followers
Acadia Pharmaceuticals
Amgen
210 followers
Thrive Capital
26 followers
Fathom
7 followers
Tarsus Pharmaceuticals
Tuckernuck
3 followers
Novo Nordisk
247 followers
GSK
253 followers
Bayer
204 followers
Explore companies